Sertindole : a review of its use in schizophrenia
- PMID: 16529528
- DOI: 10.2165/00023210-200620030-00005
Sertindole : a review of its use in schizophrenia
Abstract
Oral sertindole (Serdolect) is an atypical antipsychotic approved in the EU for once-daily use in patients with schizophrenia who are intolerant to at least one other antipsychotic agent. Extensive data from post-marketing studies do not indicate an excess of overall mortality with sertindole. Sertindole is at least as effective as haloperidol and risperidone in the treatment of neuroleptic-responsive schizophrenia. Sertindole improves negative symptoms, and is also effective for the treatment of neuroleptic-resistant schizophrenia. Sertindole is generally well tolerated and is associated with a low rate of extrapyramidal symptoms (EPS). Thus, sertindole is a useful option in the treatment of patients with schizophrenia.
Similar articles
-
Long-term efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia. The Sertindole Study Group.Psychopharmacol Bull. 1998;34(1):61-9. Psychopharmacol Bull. 1998. PMID: 9564200 Clinical Trial.
-
A review of the efficacy, tolerability and safety of sertindole in clinical trials.CNS Drugs. 2004;18 Suppl 2:19-30; discussion 41-3. doi: 10.2165/00023210-200418002-00003. CNS Drugs. 2004. PMID: 15461313 Review.
-
Emerging treatments in the management of schizophrenia - focus on sertindole.Drug Des Devel Ther. 2010 Sep 7;4:187-201. doi: 10.2147/DDDT.S6591. Drug Des Devel Ther. 2010. PMID: 20856845 Free PMC article. Review.
-
Drug safety and efficacy evaluation of sertindole for schizophrenia.Expert Opin Drug Saf. 2012 Nov;11(6):1047-62. doi: 10.1517/14740338.2012.726984. Epub 2012 Sep 19. Expert Opin Drug Saf. 2012. PMID: 22992213 Review.
-
Efficacy and safety of sertindole in schizophrenia: a clinical review.J Clin Psychopharmacol. 2015 Jun;35(3):286-95. doi: 10.1097/JCP.0000000000000305. J Clin Psychopharmacol. 2015. PMID: 25830594 Review.
Cited by
-
Indole-containing pharmaceuticals: targets, pharmacological activities, and SAR studies.RSC Med Chem. 2024 Jan 30;15(3):788-808. doi: 10.1039/d3md00677h. eCollection 2024 Mar 20. RSC Med Chem. 2024. PMID: 38516587 Review.
-
Antiproliferative activities of the second-generation antipsychotic drug sertindole against breast cancers with a potential application for treatment of breast-to-brain metastases.Sci Rep. 2018 Oct 25;8(1):15753. doi: 10.1038/s41598-018-33740-0. Sci Rep. 2018. PMID: 30361678 Free PMC article.
-
A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI.Drugs R D. 2017 Mar;17(1):1-28. doi: 10.1007/s40268-016-0153-9. Drugs R D. 2017. PMID: 27853957 Free PMC article. Review.
-
The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.CNS Drugs. 2014 May;28(5):421-53. doi: 10.1007/s40263-014-0157-3. CNS Drugs. 2014. PMID: 24677189 Free PMC article. Review.
-
Critical appraisal of lurasidone in the management of schizophrenia.Neuropsychiatr Dis Treat. 2012;8:155-68. doi: 10.2147/NDT.S18059. Epub 2012 Apr 17. Neuropsychiatr Dis Treat. 2012. PMID: 22570547 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
